lobbying_activities: 3336858

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3336858	1609b792-82d5-4214-b33b-d9df2e0fbc5a	Q1	TRAVERE THERAPEUTICS	401104190	TRAVERE THERAPEUTICS	2025	first_quarter	PHA	HR 946, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act)	HOUSE OF REPRESENTATIVES,SENATE		160000	0	0	2025-04-16T12:25:40-04:00